Ebrahim Variava to Cost-Benefit Analysis
This is a "connection" page, showing publications Ebrahim Variava has written about Cost-Benefit Analysis.
Connection Strength
0,151
-
Influenza economic burden among potential target risk groups for immunization in South Africa, 2013-2015. Vaccine. 2020 10 21; 38(45):7007-7014.
Score: 0,039
-
Influenza disease burden among potential target risk groups for immunization in South Africa, 2013-2015. Vaccine. 2020 06 02; 38(27):4288-4297.
Score: 0,038
-
Intensified household contact tracing, prevention and treatment support versus enhanced standard of care for contacts of tuberculosis cases in South Africa: study protocol for a household cluster-randomised trial. BMC Infect Dis. 2019 Oct 12; 19(1):839.
Score: 0,037
-
Quantifying How Different Clinical Presentations, Levels of Severity, and Healthcare Attendance Shape the Burden of Influenza-associated Illness: A Modeling Study From South Africa. Clin Infect Dis. 2019 08 30; 69(6):1036-1048.
Score: 0,037